Transfer of vitiligo after allogeneic bone marrow transplantation

Journal of the American Academy of Dermatology

Volumn 46, Issue 4, 2002, Pages 606-610

  Alajlan, Abdulmajeed ^a   Alfadley, Abdullah ^a   Pedersen, Kristian Thestrup ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ADULT; ALLOGENEIC RESTRICTION; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; DONOR; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNE SYSTEM; IMMUNITY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; VITILIGO;

EID: 0036553481     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.117215     Document Type: Article

References (44)

1. Mahmoud F, Abul H, Al-Saleh Q, Haines D, Burleson J, Morgan G. Peripheral T-cell activation in non-segmental vitiligo. J Dermatol 1998;25:637-40.
2. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148:1219-28.
3. Ahn SK, Choi EH, Lee SH, Won JH, Hann SK, Park YK. Immunohistochemical studies from vitiligo-comparison between active and inactive lesions. Yonsei Med J 1994;35:404-10.
4. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993;170:149-55.
5. Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 1997;109:495-500.
6. Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 1995;22:245-60.
7. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N.The role of tyrosinase in autoimmune vitiligo. Lancet 1994;344: 1049-52.
8. Naughton GK, Eisinger M, Bystryn JC. Antibodies to normal human melanocytes in vitiligo. J Exp Med 1983;158:246-51.
9. Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998;188:1203-8.
10. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. Transplantation 1988;46:238-40.
11. Garver RM, Santos GW, Cole LJ. Specific hemagglutinins in x-irradiated, bone-marrow treated mice following differential immunization of host and donor. J Immunol 1959;83:57-65.
12. Stoner RD, Bond VP. Antibody formation by transplanted bone marrow, spleen, lymph nodes and thymus cells in irradiated recipients. J Immunol 1963;91:185-96.
13. Holt PG, Leivers S, Batty J. Adaptive transfer of 'persistent' IgE responses in mice in the absence of secondary antigenic stimulation. Int Arch Allergy Appl Immunol 1981;66:357-64.
14. Chin PH, Silverman MS. Studies on the transfer of antibody formation by iso- and heterotransplants. J Immunol 1960;85:120-9.
15. Nakano K, Mordes JP, Handler ES, Greiner DL, Rossini AA. Role of host immune system in BB/Wor rat: predisposition of diabetes resides in bone marrow. Diabetes 1988;37:520-5.
16. Wicker LS, Miller BJ, Chai A, Terada M, Mullen Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow derived cells: transfer of diabetes and insulitis to nondiabetic (NOD x B10) F1 mice with bone marrow cells from NOD mice. J Exp Med 1988;167:1801-10.
17. Morton JL, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci U S A 1974;71:2162-8.
18. Ikehara S, Yasumizu R, Inaba M, Izui S, Hayakawa K, Sekita K, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 1989;86:3306-10.
19. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol 1990;74:118-20.
20. Kishimoto Y, Yamamoto Y, Ito T, Matsumoto N, Ichiyoshi H, Katsurada T, et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone morrow transplantation. Bone Marrow Transplant 1997; 19:1041-3.
21. Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B. Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 1990;5:357-61.
22. Waters AH, Metcalfe P, Minchinton RM, Barrett AJ, James DC. Autoimmune thrombocytopenia acquired from allogeneic bone marrow graft: compensated thrombocytopenia in bone marrow donor and recipient [letter]. Lancet 1983;2:1430.
23. Walker SA, Riches PG, Wild G, Milford Ward AM, Shaw PJ, Desai S, et al. Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol 1986;66:633-9.
24. Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R, et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319:1623-8.
25. Tucker J, Barnetson RS, Eden OB. Atopy after bone marrow transplantation. BMJ 1985;290:116-7.
26. Saarinen UM. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol 1984;74:196-200.
27. Bellou A, Kanny G, Fremont S, Moneret-Vautrin DA. Transfer of atopy following bone morrow transplantation. Ann Allergy Asthma Immunol 1997;78:513-6.
28. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;341:124-4.
29. Smith CI, Aarli JA, Biberfeld P, Bolme P, Christensson B, Gahrton G, et al. Myasthenia gravis after bone marrow transplantation: evidence for a donor origin. N Engl J Med 1983;309:1565-8.
30. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Andre JPS, Verret JL. Psoriasis after allogeneic bone marrow transplantation [letter]. Arch Dermatol 1990;126:1523.
31. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 1997;137: 130-2.
32. Baldwin JL, Storb R,Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977;20:1043-8.
33. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993;20:137-40.
34. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998;41:453-9.
35. Saurat JH. Eczema in primary immune-deficiencies. Acta Derm Venereol 1985;114:125-8.
36. Lui-Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1992;9:31-3.
37. Eedy DJ, Burrows D, Bridges JM, Jones FGC. Clearance of severe psoriasis after allogeneic bone marrow transplantation. BMJ 1990;300:908.
38. Vento S, Cainelli F, Renzini C, Ghironzi G, Concia E. Resolution of autoimmune hepatitis after bone marrow transplantation. Lancet 1996;348:544-5.
39. LaFace DM, Peck AB. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 1989;38:894-901.
40. Venkataram MN, White AG, Leeny WA, AI Suwaid AR, Daar AS. HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol 1995;20:35-7.
41. Al-Fouzan A, Al-Arbash M, Fouad F, Kaaba SA, Mousa MA, Al-Harbi SA. Study of HLA class 1/11 and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 1995;22:209-13.
42. Venneker GT, de Waal LP, Westerhof W, D'Amaro J, Schreuder GM, Asghar SS. HLA associations in vitiligo patients in the Dutch population. Dis Markers 1993;11:187-90.
43. Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y. Vitiligo is associated with a significant increase in HLA-A30, CW6 and DQW3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 1992;185:123-7.
44. Aubin F, Cahn JY, Ferrand C, Angonin R, Humbert P, Tiberghien P. Extensive vitiligo after gancyclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet 2000;355:626-7.